BreakThru SCI is helping guide the pivotal, first-of-its-kind Patient-Focused Drug Development Meeting (PFDD) for spinal cord injury, serving as an active member of the Steering Committee.

The primary goal of patient-focused drug development (PFDD) is to better incorporate the patient’s voice in drug development and evaluation. The virtual meeting will capture data about SCI community experiences, covering daily impacts, treatment experiences, and meaningful tradeoffs, using a standardized, discussion-based format. 

Click below to learn more about this historic meeting; our goal is to gather as many virtual attendees as possible to make the FDA pay attention to the urgent unmet needs of SCI. Every dial-in matters.